Astoundingly, 'Pink Viagra' Is Once Again in the News.

More than a decade ago, Addyi—marketed as the “female Viagra”—was approved amid political pressure, heavy lobbying, and a lot of hype. The problem then, as now, is simple: the drug barely works and causes enough side effects that many women stop taking it. Yet, in what can only be described as an FDA boner, the agency has expanded the indication to older women.